Suchergebnisse - "Receptors, Phospholipase A2"

PubPharm (758)

51

The expanding spectrum and utility of antigens in membranous nephropathy

enthalten in: Current opinion in nephrology and hypertension | 2023

von Miller, P. | Caza, T.

52

Experimental evidence for a pathogenic role of anti-PLA2R1 antibodies in membranous nephropathy

enthalten in: Nature reviews. Nephrology | 2023

von Carney, E.

CommentOn: J Am Soc Nephrol. 2023 Mar 1;34(3):369-373. - PMID 36735391

53

Clinical Significance of Thrombospondin Type 1 Domain-Containing 7A and Neural Epidermal Growth Factor-Like 1 Protein in M-Type Phospholipase A2 Receptor-Negative Membranous Nephropathy

enthalten in: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae | 2023

von Tang, X. | DU, Y. | Yu, J. | +4

54

Personalized Treatment of PLA2R-Related Membranous Nephropathy

enthalten in: Clinical journal of the American Society of Nephrology : CJASN | 2023

von Fernández-Juárez, G. | Ronco, P. | Jha, V.

55

The role of PLA2R antibody monitoring : what we know and what we do not know

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2023

von Ronco, P. | Plaisier, E. | Debiec, H.

56

Anti-PLA2R1 antibodies in membranous nephropathy : do we have the smoking gun?

enthalten in: Kidney international | 2023

von Fribourg, M. | Cravedi, P.

CommentOn: Kidney Int. 2023 Feb;103(2):297-303. - PMID 36191868

57

The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy

enthalten in: European journal of medical research | 2023

von Cheng, Y. | Wang, M. | Wang, J. | +2

ErratumIn: Eur J Med Res. 2023 Apr 5;28(1):148. - PMID 37020299

58

Discovery of seven novel putative antigens in membranous nephropathy and membranous lupus nephritis identified by mass spectrometry

enthalten in: Kidney international | 2023

von Caza, T. | Storey, A. | Hassen, S. | +5

CommentIn: Kidney Int. 2023 Mar;103(3):469-472. - PMID 36822753

59

Intravenous cyclophosphamide as an alternative to the oral cyclophosphamide modified Ponticelli regimen for high-risk PLA2R-positive membranous nephropathy

enthalten in: Journal of nephrology | 2023

von Ștefan, G. | Zugravu, A. | Stancu, S.

60

Accuracy of serum PLA2R antibody detected by indirect immunofluorescence in diagnosing biopsy-proven primary membranous nephropathy : a single-center experience and a systematic review of the literature

enthalten in: Journal of nephrology | 2023

von Allinovi, M. | Lugli, G. | Rossi, F. | +5